Abstract:Intracellular bacterial infection is one of the most life‐threatening cases of drug resistance, and photodynamic therapy is challenged by intermittent light illumination and unspecific host toxicity. Herein, a concise strategy is demonstrated to enable real‐time detection and on‐demand eradication of intracellular bacteria in response to intrabacterial nitroreductase and avoid damages to host cells by the intracellularly generated reactive oxidative species. Intracellular bacterial (ICB) infection is one of the most life‐threatening cases of drug resistance, and photodynamic therapy (PDT) is challenged by limited light penetration into tissues and unspecific toxicity to host cells. Herein, theranostic nanoparticles (NPs) are developed to facilitate on‐demand activation of photosensitizers inside ICBs and persistent PDT of deep‐tissue ICB infections. Mechanoluminescent SrAl2O4:Eu2+ and persistence luminescent CaS:Eu2+ are sequentially deposited on mesoporous silica to prepare mSC, followed by encapsulation by bacterial membranes with loaded nitroreductase (NTR)‐activatable methylene blue (nMB) to obtain mSC‐nMB@BM NPs. The fluorescence quenching of nMB with mSC offers few cytotoxicities even under ultrasonication, and bacterial membrane coatings mediate the specific NP internalization into ICB‐infected macrophages. Bacterial pore‐forming toxins trigger nMB release from NPs, and intrabacterial NTR rejuvenates methylene blue probes from nMB for real‐time imaging of ICB infections. Ultrasonication of NPs continuously excites the rejuvenated methylene blue to generate reactive oxidative species and reduce viable ICBs by 3.54 log magnitude folds. NP treatment on ICB‐infected mice exhibits full survival and restores viscera functions without any pathological abnormality. Therefore, this concise NP design demonstrates capabilities of bacterial membrane‐mediated specific internalization, bacterial toxin‐triggered release and intrabacterial NTR‐rejuvenation of fluorescent probes, and persistent internal light‐illumination for ICB theranostics.

Ultrasound-Activated Persistent Luminescence Imaging and Bacteria-Triggered Drug Release for Helicobacter Pylori Infection Theranostics

A pH-Responsive Persistent Luminescence Nanozyme for Selective Imaging and Killing of Helicobacter pylori and Common Resistant Bacteria

Oral Ph Sensitive GNS@ab Nanoprobes for Targeted Therapy of Helicobacter Pylori Without Disturbance Gut Microbiome.

Mucus‐Penetrating Nanoassembly as Potential Oral Phototherapeutic Formulation against Multi‐Drug Resistant Helicobacter pylori Infection

Persistent Luminescence-Based Theranostics for Real-Time Monitoring and Simultaneously Launching Photodynamic Therapy of Bacterial Infections.

Antibody-conjugated liposomes loaded with indocyanine green for oral targeted photoacoustic imaging-guided sonodynamic therapy of Helicobacter pylori infection

In situ targeted MRI detection of Helicobacter pylori with stable magnetic graphitic nanocapsules

Folic Acid‐Modified Nanoprobe for in Vivo Targeted Persistent Luminescence Imaging and pH‐Responsive Antibiotic Therapy of Bacterial Infection

Oral Antibody-Conjugated Liposomes Loaded with Indocyanine Green for Targeted Photoacoustic Imaging Directed Sonodynamic Therapy of H.Pylori

Infection Microenvironment-Mediated Nanoplatform for In Vivo Persistent Luminescence Imaging and Chemodynamic Antibacterial Therapy

Rhamnolipid-assisted black phosphorus nanosheets with efficient isolinderalactone loading against drug resistant Helicobacter pylori

Combating drug-resistant helicobacter pylori infection with zinc peroxide-based nanoparticles: A ROS reservoir via photochemical reaction

Intrabacterial Nitroreductase‐Activated Imaging and Persistently Illuminated Photodynamic Therapy for Intracellular Infection Theranostics

Helicobacter pylori-targeting multiligand photosensitizer for effective antibacterial endoscopic photodynamic therapy

Targeted Sonodynamic Therapy Platform for Holistic Integrative Helicobacter pylori Therapy

pH Switchable Nanoplatform for In Vivo Persistent Luminescence Imaging and Precise Photothermal Therapy of Bacterial Infection

Cascaded Nanozyme Based pH‐Responsive Oxygenation for Targeted Eradication of Resistant Helicobacter Pylori

Protonated Charge Reversal Nanodrugs for Active Targeting Clearance of Helicobacter Pylori Accompanied by Gut Microbiota Protection

Metal‐Organic Framework Based Mucoadhesive Nanodrugs for Multifunction Helicobacter Pylori Targeted Eradication, Inflammation Regulation and Gut Flora Protection

Responsive nanoplatform for persistent luminescence “turn-on” imaging and “on-demand” synergistic therapy of bacterial infection

Biodegradable Acid‐Responsive Nanocarrier for Enhanced Antibiotic Therapy Against Drug‐Resistant Helicobacter Pylori via Urease Inhibition